Receptos Inc., of San Diego, said it completed its initial public offering of 5.2 million shares priced at $14 apiece for proceeds of $72.8 million and granted underwriters Credit Suisse Securities LLC, Leerink Swann LLC, BMO Capital Markets and Wedbush PacGrow Life Sciences a 30-day option to purchase up to an additional 780,000 shares to cover overallotments

BMO Capital Markets, Cowen and Co

William Blair $115 Receptos Inc. (San Diego; RCPT)5 4/4/13 4.7S $14-$16 17.1 Credit Suisse Leerink Swann (co-lead) BMO Capital Markets (co-lead) Wedbush PacGrow Life Sci. $70.5 Regado Biosciences Inc. (Basking Ridge, N.J.; RGDO) 4/29/13 N/A N/A N/A Cowen & Co...BMO Capital Markets (co-lead) Canaccord Genuity Needham & Co

LLC and BMO Capital Markets would act as joint book-running managers for the IPO, joined by co-managers Canaccord Genuity Inc., Needham & Co

BMO Capital Markets Baird $22.2 ($97.2 total raised) $586.26 Total: $608.92M Number of follow-on offerings in March: 10 Average value of March follow-ons: $60.89M Number of follow-on offerings in 2013: 32 Total raised in follow-ons in 2013: $3,001.2M Average value of follow-ons in 2013: $93.79M Notes: # Unless otherwise indicated, shares are traded on the Nasdaq exchange...FILED AND PENDING Company (Symbol)#* Date Filed Shares/Units (M) Price Shares Out Lead, Other Underwriters Gross (US$M

Credit Suisse, Leerink Swann, Wedbush PacGrow Life Sciences and BMO Capital Markets are serving as underwriters for the proposed IPO

Affymax already has proven its candidate noninferior to Epogen, and made publicly known that the price would be competitive, a relief to dialysis providers squeezed by the Centers for Medicare & Medicaid Services bundling rules. (See BioWorld Insight, Dec. 19, 2011, and BioWorld Today, Dec. 8, 2011.) Jim Birchenough, analyst with BMO Capital Markets, wrote in a research note at the time of the FDA panel vote that Omontys price discounts could win Affymax the one-third of the dialysis market

Barclays and BMO Capital Markets are the handling the IPO. (See BioWorld Today, Feb. 13, 2013

BMO Capital Markets Baird $75 N/A Ventrus Biosciences Inc. (New York; VTUS)6 2/10/12 2/4/13 6.67S and 0.22S of Series A $2.50 and $25 18.73 William Blair $22.2 $46.825 Total: $269.06M Number of follow-on offerings in February: 8 Average value of February follow-ons: $33.63M Number of follow-on offerings in 2013: 23 Total raised in follow-ons in 2013: $2,465.86M Average value of follow-ons in 2013: $107.2M Notes: # Unless otherwise indicated, shares are traded on the Nasdaq exchange...MLV & Co

Citigroup and Leerink Swann are joint book-running managers for the proposed IPO, with BMO Capital Markets acting as lead manager and Robert W. Baird & Co

and BMO Capital Markets Corp

Piper Jaffray JMP Securities $185.2 $1.24B Anthera Pharmaceuticals Inc. (Hayward, Calif.; ANTH)5 1/24/12 1/24/13 60.6S $0.66 79.1 Jefferies Leerink Swann $40 $52.2 Ariad Pharmaceuticals Inc. (Cambridge, Mass.; ARIA)6 12/14/11 1/24/13 16.5S $19.60 183.1 J.P. Morgan Cowen & Co. (co-lead) Jefferies (co-lead) BMO Capital Markets Leerink Swann RBC Capital Markets UBS Investment Bank $323.4 $3.59B Arrowhead Research Corp. (Pasadena, Calif.; ARWR) 8/17/11 1/25/13 1.65U $2.12 N/A Dawson James

BMO Capital Markets (2/5) $424.00 21 Wells Fargo Securities (3/4) $420.00 22 Barclays Capital (3/3) $386.07 23 RBC Capital Markets (1/5) $317.00 24 Goldman, Sachs & Co. (3/3) $297.18 25 Deutsche Bank Securities (3/3) $291.07 26 Ladenburg, Thalmann (0/5) $246.00 27 Summer Street Research (2/6) $201.00 28 UBS Investment (1/2) $200.85 29 Mizuho Securities (0/1) $145.00 30 Collins Stewart LLC (0/2) $130.68 31 Griffin Securities Inc. (0/2) $130.18 32 Aegis Capital Corp. (8/8) $127.52 33 Brean Murray

Full Credit to All Underwriters, Ranked by After-Market Performance*# Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) After-Market Performance (Average) 1 ThinkEquity LLC (0/1) +128% 2 Goldman, Sachs & Co. (1/1) +89% 3 BMO Capital Markets (2/3) +71% 4 Wedbush PacGrow Life Sciences (0/3) +57% 5 Needham & Co. (0/4) +52% 6 Lazard Capital Markets (1/3) +45% 7 Piper Jaffray (1/1) +43% 8 Bank of America Merrill Lynch (3/3) +33% 9 J.P. Morgan Securities (3/3) +28% 10 Citigroup Global

Ranked by After-Market Performance*# Rank Underwriter (Offerings as Lead/Offerings as Lead or Co-Manager) After-Market Performance (Average) 1 ThinkEquity LLC (0/1) +128% 2 Mizuho Securities (0/1) +88% 3 Brean Murray, Carret (0/2) +77% 4 MLV & Co. (0/1) +70% 5 Chardan Capital Markets (0/1) +70% 6 BMO Capital Markets (2/5) +49% 7 Morgan Stanley (7/7) +36% 8 Wedbush PacGrow Life Sciences (1/11) +32% 9 Goldman, Sachs & Co. (3/3) +27% 10 Barclays Capital (3/3) +26% 11 Robert W. Baird (0/1) +26% 12

BMO Capital Markets (2/5) $137.00 19 Aegis Capital Corp. (8/8) $127.52 20 Roth Capital Partners (5/17) $93.00 21 UBS Investment (1/2) $63.25 22 RBC Capital Markets (1/5) $39.00 23 Summer Street Research (2/6) $32.00 24 Wedbush PacGrow Life Sciences (1/11) $23.00 25 Canaccord Genuity (1/12) $21.45 26 Forham Financial Management (1/1) $18.00 27 Maxim Group LLC (2/5) $13.00 28 Dawson James Securities (1/1) $4.00 * The offerings in this chart include only those that were completed on U.S

Ranked by After-Market Performance*# Rank Underwriter (Offerings as Lead/Offerings as Lead or Co-Manager) After-Market Performance (Average) 1 BMO Capital Markets (2/5) +93% 2 RBC Capital Markets (1/5) +82% 3 Morgan Stanley (7/7) +36% 4 Wells Fargo Securities (3/4) +33% 5 Goldman, Sachs & Co. (3/3) +27% 6 Barclays Capital (3/3) +26% 7 Jefferies & Co. (21/21) +25% 8 Bank of America Merrill Lynch (10/12) +22% 9 Maxim Group LLC (2/5) +22% 10 J.P. Morgan Securities (18/18) +16% 11 Forham Financial

Full Credit to Lead Underwriter, Ranked by After-Market Performance*# Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) After-Market Performance (Average) 1 BMO Capital Markets (2/3) +93% 2 Goldman, Sachs & Co. (1/1) +89% 3 Lazard Capital Markets (1/3) +58% 4 Piper Jaffray (1/1) +43% 5 Bank of America Merrill Lynch (3/3) +33% 6 J.P. Morgan Securities (3/3) +28% 7 Citigroup Global Markets (including citibank) (3/3) +26% 8 Cowen & Co. (3/6) +26% 9 Morgan Stanley (1/1) +26% 10 Leerink

Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) Gross Proceeds (M) 1 Cowen & Co. (3/6) $368.00 2 Leerink Swann (4/5) $346.51 3 Bank of America Merrill Lynch (3/3) $263.98 4 Needham & Co. (0/4) $252.61 5 J.P. Morgan Securities (3/3) $232.85 6 BMO Capital Markets (2/3) $224.00 7 Wedbush PacGrow Life Sciences (0/3) $215.00 8 Lazard Capital Markets (1/3) $195.15 9 Citigroup Global Markets (including citibank) (3/3) $189.00 10